Vivani Medical, Inc. Common Stock (DE) financials
$1.23−1.60%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — |
| Operating income | -$27.6M | -$24.7M | -$27.0M | -$13.9M |
| Net income | -$26.6M | -$23.5M | -$25.7M | -$13.9M |
| Net margin | — | — | — | — |
| Diluted EPS | $-0.43 | $-0.43 | $-0.50 | $-0.36 |
| EBITDA | -$27.1M | -$24.3M | -$26.6M | -$13.5M |
| Operating cash flow | -$24.3M | -$20.8M | -$23.7M | -$18.8M |
| Free cash flow | -$25.5M | -$21.3M | -$24.6M | -$19.1M |
| Diluted shares | 62.4M | 55.0M | 50.9M | 38.2M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $16.2M | $18.4M | $20.7M | $45.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $39.4M | $41.6M | $45.8M | $51.1M |
| Total liabilities | $23.7M | $24.0M | $25.0M | $6.8M |
| Shareholders' equity | $15.7M | $17.6M | $20.8M | $44.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology